ALZHEON, INC.

Profile

Company Names

ALZHEON, INC.

Addresses

111 SPEEN STREET, SUITE 306, FRAMINGHAM, MA 01701

394 LOWELL STREET, SUITE 9, LEXINGTON, MA 02420

11 BLOSSOM CIRCLE, NATICK, MA 01760

Phone Numbers

650-392-9186
857-214-7242

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$172,460,887.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-02-27 
$126,259,938.00 
$150,000,000.00 
$23,740,062.00 
Equity 
8
2022-12-27 
$1,703,768.00 
$50,004,201.00 
$48,300,433.00 
Equity 
7
2020-09-16 
$2,432,016.00 
$50,000,004.00 
$47,567,988.00 
Equity 
6
2019-04-25 
$6,163,716.00 
$6,163,716.00 
$0.00 
Equity 
5
2017-05-25 
$19,801,820.00 
$19,801,820.00 
$0.00 
Equity 
4
2016-02-04 
$1,300,000.00 
$5,000,000.00 
$3,700,000.00 
Debt 
3
2015-07-13 
$6,905,000.00 
$6,905,000.00 
$0.00 
Debt 
2
2014-12-30 
$7,344,629.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2013-07-23 
$550,000.00 
$550,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUSAN 
 
ABUSHAKRA, M.D. 
EXECUTIVE OFFICER
MICHAEL 
 
ACETI 
EXECUTIVE OFFICER
ADEM 
 
ALBAYRAK 
EXECUTIVE OFFICER
MENGHIS 
 
BAIRU 
DIRECTOR
ADAM 
HALE 
BROCKMAN 
EXECUTIVE OFFICER
CHRISTOPHER 
NOEL 
DUNN 
DIRECTOR
NOEL 
 
DUNN 
DIRECTOR
NEIL 
W. 
FLANZRAICH 
DIRECTOR
JEAN-PIERRE 
 
GARNIER 
DIRECTOR
JORDAN 
 
HELLER 
DIRECTOR
JOHN 
 
HEY 
EXECUTIVE OFFICER
JOHN 
ANTHONY 
HEY 
EXECUTIVE OFFICER
JOHN 
 
HEY, PH.D. 
EXECUTIVE OFFICER
DIANE 
K. 
JORKASKY, M.D. 
DIRECTOR
KEN 
 
MACE 
EXECUTIVE OFFICER
KENNETH 
A. 
MACE 
EXECUTIVE OFFICER
GREGORY 
LEON 
MILLER 
EXECUTIVE OFFICER
DAVID 
 
NIKODEM 
DIRECTOR
DAVID 
 
NIKODEM, PH.D. 
DIRECTOR
GLENN 
E. 
PAULY 
EXECUTIVE OFFICER
AIDAN 
 
POWER, MRCPSYCH 
EXECUTIVE OFFICER
MUNEER 
 
SATEER 
DIRECTOR
MARTIN 
 
TOLAR 
EXECUTIVE OFFICER, DIRECTOR
MARTIN 
 
TOLAR, M.D., PH.D. 
DIRECTOR, EXECUTIVE OFFICER
MARK 
 
VERSAVEL 
EXECUTIVE OFFICER
JEREMY 
YONGXIN 
YU 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-02-27 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-02-27 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-02-27 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-27 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-04-25 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-07-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
CIM SECURITIES, LLC
NONE
NONE
NONE
CIM SECURITIES, LLC
NONE
NONE
BROOKLINE GROUP, LLC